Baraldi Eugenio, Bonetto Gea, Zacchello Franco, Filippone Marco
Department of Pediatrics, School of Medicine, University of Padova, Via Giustiniani 3, 35128 Padova, Italy.
Am J Respir Crit Care Med. 2005 Jan 1;171(1):68-72. doi: 10.1164/rccm.200403-298OC. Epub 2004 Oct 11.
Bronchopulmonary dysplasia (BPD), the chronic lung disease of prematurity, may be associated with long-term airflow limitation. Survivors of BPD may develop asthma-like symptoms in childhood, with a variable response to beta(2)-agonists. However, the pathologic pathways underlying these respiratory manifestations are still unknown. The aim of this study was to measure exhaled nitric oxide (FE(NO)) and lung function in a group of 31 school-age survivors of BPD. They showed variable degrees of airflow obstruction (mean FEV(1) 77.8 +/- 2.3% predicted) unresponsive to beta(2)-agonists in 72% of the subjects. Their FE(NO) values (geometric mean [95% confidence interval]: 7.7 [+/- 1.1] ppb) were significantly lower than in a group of healthy matched control subjects born at term (10.7 [+/- 1.1] ppb, p < 0.05) and a group of preterm children without BPD (9.9 [+/- 1.1] ppb, p < 0.05). The children with BPD were also compared with a group of 31 patients with asthma with a comparable airflow limitation (FEV(1) 80.2 +/- 2.1% predicted) and showed FE(NO) values four times lower than in those with asthma (24.9 [+/- 1.2] ppb, p < 0.001). In conclusion, unlike children with asthma, school-age survivors of BPD have airflow limitation associated with low FE(NO) values and lack of reversibility to beta(2)-agonists, probably as a result of mechanisms related to early life structural changes in the airways.
支气管肺发育不良(BPD)是一种早产相关的慢性肺部疾病,可能与长期气流受限有关。BPD幸存者在儿童期可能出现类似哮喘的症状,对β2受体激动剂的反应各异。然而,这些呼吸表现背后的病理途径仍不清楚。本研究的目的是测量31名BPD学龄期幸存者的呼出气一氧化氮(FE(NO))和肺功能。他们表现出不同程度的气流阻塞(平均FEV(1)为预测值的77.8 +/- 2.3%),72%的受试者对β2受体激动剂无反应。他们的FE(NO)值(几何平均值[95%置信区间]:7.7 [+/- 1.1] ppb)显著低于一组足月出生的健康匹配对照受试者(10.7 [+/- 1.1] ppb,p < 0.05)和一组无BPD的早产儿童(9.9 [+/- 1.1] ppb,p < 0.05)。还将患有BPD的儿童与一组31名气流受限程度相当(FEV(1)为预测值的80.2 +/- 2.1%)的哮喘患者进行比较,结果显示他们的FE(NO)值比哮喘患者低四倍(24.9 [+/- 1.2] ppb,p < 0.001)。总之,与哮喘儿童不同,BPD学龄期幸存者存在气流受限,FE(NO)值较低且对β2受体激动剂缺乏反应性改变,这可能是由于气道早期结构变化相关机制所致。